Clinical trials
Phase 2 Scleroderma, Systemic trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Active Biotech AB | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Galderma R&D | 1 |
| Heidelberg University | 1 |
| Novartis Pharmaceuticals | 1 |
| Sanofi | 1 |
| Topadur Pharma AG | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 10 |
| Lung Diseases, Interstitial | 2 |
| Scleroderma, Diffuse | 2 |
| Familial Primary Pulmonary Hypertension | 1 |
| Fibrosis | 1 |
| Hypertension, Pulmonary | 1 |
| Scleroderma, Limited | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.